Radiologist and nuclear medicine specialist, Dr Liesl Celliers, has been appointed in a new position which aims to fast-track cancer research at the Harry Perkins Institute of Medical Research.
The new position has resulted from an exciting new collaboration between the Harry Perkins Institute of Medical Research and Perth Radiological Clinic’s charity the PerthRadClinic Foundation.
Together they have established the Perth Radiological Clinic Associate in Translational Imaging – a three year clinical research position at the Harry Perkins Institute of Medical Research in Nedlands.
“It’s an exciting collaboration for us” says Perth Radiological Clinic Chairman Dr Martin Blake.
“One of the key drivers for us when we established the PerthRadClinic Foundation was to support innovation in medicine and being involved with the Perkins in this way is a perfect fit for us. The new position is intimately involved with the imaging side of preclinical cancer research and looking at how breakthroughs in preclinical model research can be translated to human clinical trials. As the premier provider of diagnostic medical imaging services in Western Australia it’s a privilege to be in a position to support this very valuable research”.
Dr Celliers received her Bachelor of Medicine and Surgery from the University of Melbourne and then trained as a radiologist and a nuclear medicine specialist.
She has had broad exposure to various public and private diagnostic settings during her work at hospitals in Melbourne and Perth.
Perkins Director, Professor Peter Leedman, said he was pleased to welcome Dr Celliers to the Institute and was looking forward to seeing more discoveries translate into better health outcomes for the community.
“This is the first time we’ve had a radiologist specialising in nuclear medicine at the Institute,” Professor Leedman said.
“We’re extremely grateful to the PerthRadClinic Foundation, chaired by Dr Martin Blake and his colleagues who have made this possible with a generous gift over a number of years.”
Dr Celliers said she was looking forward to facilitating the advancement of promising research into human clinical trials.
“My role involves evaluating cancer research projects and offering strategic advice, using my background in molecular imaging and oncology.”
“I’ll be working with a team of clinical and bio-resource experts to help channel laboratory discoveries into new medicines to treat patients,” Dr Celliers said.
Dr Celliers said she hoped her work would lead to earlier disease detection, discovery of better prevention strategies and new cancer treatment tests.